Literature DB >> 10082232

Treatment resistant depression: methodological overview and operational criteria.

D Souery1, J Amsterdam, C de Montigny, Y Lecrubier, S Montgomery, O Lipp, G Racagni, J Zohar, J Mendlewicz.   

Abstract

A wide variety of definitions are used for Treatment Resistant Depression (TRD), considering various criteria and different concepts. Some of the key issues are: the diagnosis, the treatment adequacy in terms of dose and duration, the treatment response assessment and the number of failed therapeutic trials required. Systematic research has been characterizing the concept and criteria to define the different variables involved. Lack of consensus on these issues limits comparison across clinical trials and interpretation of treatment efficacy in the management of treatment resistant patients. Through reanalyzes of available data, we point out the limits of TRD definitions and propose conceptual and operational criteria for a collaborative research project on TRD. It appears that a number of variables commonly associated to treatment resistance are independent of patients characteristics and mainly refer to misdiagnosis and inadequate treatment. The proposed criteria are intended for therapeutic trials in TRD, combining the evaluation of treatment efficiency and the validation of the concept of TRD itself. Major depression with poor response to two adequate trials of different classes of antidepressants is proposed for an operational definition of TRD. Rationale for this definition is discussed in contrast to alternative definitions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082232     DOI: 10.1016/s0924-977x(98)00004-2

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  77 in total

1.  Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.

Authors:  S M Dursun; S Devarajan
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

2.  Pharmacologic management of refractory depression.

Authors:  S Chehil; S Devarajan; S M Dursun
Journal:  Can Fam Physician       Date:  2001-01       Impact factor: 3.275

3.  Acute exercise improves physical sexual arousal in women taking antidepressants.

Authors:  Tierney A Lorenz; Cindy M Meston
Journal:  Ann Behav Med       Date:  2012-06

Review 4.  [Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].

Authors:  H-J Möller
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 5.  Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review.

Authors:  Ranak B Trivedi; Jason A Nieuwsma; John W Williams
Journal:  J Gen Intern Med       Date:  2010-12-24       Impact factor: 5.128

6.  Sub-hubs of baseline functional brain networks are related to early improvement following two-week pharmacological therapy for major depressive disorder.

Authors:  Yuedi Shen; Jiashu Yao; Xueyan Jiang; Lei Zhang; Luoyi Xu; Rui Feng; Liqiang Cai; Jing Liu; Jinhui Wang; Wei Chen
Journal:  Hum Brain Mapp       Date:  2015-04-30       Impact factor: 5.038

7.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

8.  Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.

Authors:  Jose J Miguel-Hidalgo; Angela Whittom; Ashley Villarreal; Madhav Soni; Ashish Meshram; Jason C Pickett; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Affect Disord       Date:  2014-02-10       Impact factor: 4.839

Review 9.  Treatment-resistant depression: are animal models of depression fit for purpose?

Authors:  Paul Willner; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

10.  Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.

Authors:  Rebecca B Price; Dikoma C Shungu; Xiangling Mao; Paul Nestadt; Chris Kelly; Katherine A Collins; James W Murrough; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.